Emmanuelle Charpentier

Biography
Emmanuelle Charpentier is a pioneering microbiologist, geneticist, and biochemist whose work reshaped modern biology and medicine. She is best known for uncovering key mechanisms of the bacterial CRISPR-Cas immune system and, with Jennifer Doudna, developing CRISPR-Cas9 as a programmable genome-editing technology. Their discovery transformed the ability to precisely modify DNA, opening new paths for biomedical research, diagnostics, agriculture, and therapeutic development. Charpentier’s research has bridged fundamental microbiology and translational impact, revealing how bacteria regulate virulence and adapt to their environment while creating one of the most powerful tools in the life sciences. Her career across Europe reflects a rare mix of curiosity-driven science, institutional leadership, and field-changing translation. She is the Founding, Scientific and Managing Director of the Max Planck Unit for the Science of Pathogens in Berlin. In 2020, she received the Nobel Prize in Chemistry, shared with Doudna, for the development of a method for genome editing.